Celltrion to Conduct Trial of Remsima as COVID-19 Therapeutics in UK
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
FREE NEWSLETTER
Trending posts
- LG Releases Premium 2021 TV Lineup for Immersive Home Entertainment
239 total views, 2 views today
- Carlyle Group Buys $200 Million Worth Shares of Kakao Mobility
151 total views, 1 views today
- South Korea Partners with Hyundai, LG, KST for EV Battery Reuse
170 total views, 2 views today
- Hanwha to Strengthen Future Space Industry Growth With ‘Space Hub’
116 total views, 3 views today
- South Korea to Unveil Prototype of First Developed Fighter Jet KF-X
116 total views, 1 views today
- LG, Luxoft Join Hands to Officially Launch Automotive Solution Alluto
122 total views, 1 views today
- Naver Affiliate LINE Games Secures 100 Bln Won from China Firm Tencent
257 total views, 12 views today
- Samsung Shuts Down Texas Semiconductor Plant Due to Winter Storms
143 total views, 2 views today
- Coupang Files IPO in US for Next-Generation E-commerce Experience
95 total views, 1 views today
- Spotify Pulls Out K-Pop Music Provided by Kakao M
107 total views
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |